American Society of Hematology

Medical Student Hematology Course Learning Objectives

The ASH Medical Student Hematology Course Learning Objectives Project is designed to aid course directors in curriculum development and implementation of competencies for second-year medical students. These objectives are only a template and are not all-inclusive, but they may be useful as a guide for your course. In addition, they can be used by students to prepare for the hematology section of the United States Medical Licensing Exam. These objectives may become a foundation for the development of higher learning objectives for hematology fellows.
Subscribe to RSS
  • Myelodysplastic Syndrome Mar 12, 2014

    The myelodysplastic syndromes are clonal hematopoietic disorders that commonly cause macrocytic anemia in older patients. While the progeny of the mutant stem cells dominate the bone marrow, blood cell production rates are usually low because bone marrow cells do not mature normally and many of them undergo apoptosis in the bone marrow before reaching the peripheral blood.

  • Chronic Lymphocytic Leukemia Mar 12, 2014

    Chronic lymphocytic leukemia (CLL) is the most common form of leukemia. Patients can live many years with CLL, and may be followed by internists or family physicians. Thus it is key to know complications that may occur in patients with CLL.

  • Hodgkin Lymphoma: Learning Objectives Mar 12, 2014

    Hodgkin lymphoma is the first hematologic malignancy that was found to be curable. There are approximately 8,000 new cases of Hodgkin lymphoma per year in the US. It is most common in young adults, and the majority are cured and lead long productive lives.

  • Antithrombotic Therapy Mar 12, 2014

    Anticoagulants, antiplatelet agents, and fibrinolytic drugs are commonly used for treatment of arterial and venous thrombotic diseases. Each group of agents can produce bleeding as well as protect against thrombosis, so knowledge, experience, and thoughtful assessment of the risks as well as the benefits are essential. Several new antithrombotic drugs are being developed or are in clinical trials.

  • Leukocyte Function: Learning Objectives Mar 11, 2014

    Medical Importance Host defense depends on specialized blood cells that identify foreign micro organisms molecules and utilize oxidants, proteases, and other moieties to protect the host. A deficiency in number or qualitative function of leukocytes can lead to overwhelming infection.

  • Physiology of Stem Cell Transplantation: Learning Objectives Mar 11, 2014

    Medical Importance Stem cell transplantation is a treatment options for many patients with hematologic diseases. Stem cell transplantation involves eliminating a patient's hematopoietic and immune system by chemotherapy and radiotherapy and replacing it with one's own or another person's hematopoietic

  • Obstetrics-Pediatrics: Learning Objectives Mar 11, 2014

    Medical Importance The physiology of pregnancy stresses the hematopoietic system. The effects of pregnancy on blood volume, nutritional needs for red cell production, and thrombotic bleeding risks are important. The newborn has a unique hematopoietic profile that evolves with maturation. This

  • Fibrin Formation and Regulation of Hemostasis: Learning Objectives Mar 11, 2014

    Medical Importance Controlled activation of the coagulation system is essential to keep us from bleeding to death from minor trauma.  Understanding this pathway is crucial in order to understand defects in coagulation such as hemophilia, how the various coagulation tests

  • Tests of Hemostasis and Thrombosis: Learning Objectives Mar 11, 2014

    Medical Importance The screening tests of hemostasis were developed to help identify patients with hemostatic defects that could cause excessive bleeding. Screening tests are available for each of the three phases of hemostasis coagulation (fibrin clot formation), platelet plug formation,

  • Hemostatic Plug (Platelets): Learning Objectives Mar 11, 2014

    Medical Importance Optimal numbers and function of platelets are the key to cessation of bleeding from small vascular injuries. Disorders of platelet number or function can lead to bleeding from the skin, mucous membranes, brain or other sites. Tests are

1 of 4
back to top